Proteome Sciences plc (LON:PRM – Get Free Report) was down 9.9% during trading on Tuesday . The company traded as low as GBX 3.56 ($0.05) and last traded at GBX 3.56 ($0.05). Approximately 250,000 shares changed hands during mid-day trading, an increase of 38% from the average daily volume of 180,813 shares. The stock had previously closed at GBX 3.95 ($0.05).
Proteome Sciences Price Performance
The stock has a market capitalization of £11.07 million, a PE ratio of -375.00 and a beta of -0.03. The company’s 50 day moving average price is GBX 3.78 and its two-hundred day moving average price is GBX 4.01.
Proteome Sciences Company Profile
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Further Reading
- Five stocks we like better than Proteome Sciences
- Most Volatile Stocks, What Investors Need to Know
- AbbVie Stock: A Perfect Dip for Investors to Buy
- How to Capture the Benefits of Dividend Increases
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
- What is a SEC Filing?
- GitLab Stock Rebounds: The Inside Story of Its Comeback
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.